A highly potent and specific MET therapeutic protein antagonist with both ligand-dependent and ligand-independent activity. - Olwill SA; Joffroy C; Gille H; Vigna E; Matschiner G; Allersdorfer A; Lunde BM; Jaworski J; Burrows JF; Chiriaco C; Christian HJ; Hülsmeyer M; et al. (Molecular cancer therapeutics, 2013)